BIOMAT Database Logo BIOMAT Database Logo

Low-dose zidovudine for AIDS. 1989

P Sette, and P Narciso, and V Tozzi, and M P Camporiondo, and S Galgani, and G C Leoni, and G Tossini, and G Visco

UI MeSH Term Description Entries
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000386 AIDS-Related Complex A prodromal phase of infection with the human immunodeficiency virus (HIV). Laboratory criteria separating AIDS-related complex (ARC) from AIDS include elevated or hyperactive B-cell humoral immune responses, compared to depressed or normal antibody reactivity in AIDS; follicular or mixed hyperplasia in ARC lymph nodes, leading to lymphocyte degeneration and depletion more typical of AIDS; evolving succession of histopathological lesions such as localization of Kaposi's sarcoma, signaling the transition to the full-blown AIDS. ARC,Lymphadenopathy Syndrome,AIDS Related Complex,Complex, AIDS-Related,Lymphadenopathy Syndromes,Syndrome, Lymphadenopathy,Syndromes, Lymphadenopathy
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U

Related Publications

P Sette, and P Narciso, and V Tozzi, and M P Camporiondo, and S Galgani, and G C Leoni, and G Tossini, and G Visco
Zidovudine for AIDS.
May 1987, The New Zealand medical journal,
P Sette, and P Narciso, and V Tozzi, and M P Camporiondo, and S Galgani, and G C Leoni, and G Tossini, and G Visco
Low-dose interferon alpha combined with zidovudine in patients with AIDS-associated Kaposi's sarcoma.
March 1993, Journal of internal medicine,
P Sette, and P Narciso, and V Tozzi, and M P Camporiondo, and S Galgani, and G C Leoni, and G Tossini, and G Visco
Zidovudine treatment for AIDS.
January 1987, Nursing times,
P Sette, and P Narciso, and V Tozzi, and M P Camporiondo, and S Galgani, and G C Leoni, and G Tossini, and G Visco
A reduced dose of zidovudine in patients with AIDS.
April 1991, The New England journal of medicine,
P Sette, and P Narciso, and V Tozzi, and M P Camporiondo, and S Galgani, and G C Leoni, and G Tossini, and G Visco
Erythrocytosis after zidovudine for AIDS.
February 1991, Annals of internal medicine,
P Sette, and P Narciso, and V Tozzi, and M P Camporiondo, and S Galgani, and G C Leoni, and G Tossini, and G Visco
Intrathecal zidovudine for AIDS dementia.
September 1990, Lancet (London, England),
P Sette, and P Narciso, and V Tozzi, and M P Camporiondo, and S Galgani, and G C Leoni, and G Tossini, and G Visco
Intrathecal zidovudine for AIDS dementia.
July 1990, Lancet (London, England),
P Sette, and P Narciso, and V Tozzi, and M P Camporiondo, and S Galgani, and G C Leoni, and G Tossini, and G Visco
Zidovudine (AZT) aids AIDS survival.
February 1989, Hospital practice (Office ed.),
P Sette, and P Narciso, and V Tozzi, and M P Camporiondo, and S Galgani, and G C Leoni, and G Tossini, and G Visco
HIV, AIDS, and zidovudine.
March 1992, Lancet (London, England),
P Sette, and P Narciso, and V Tozzi, and M P Camporiondo, and S Galgani, and G C Leoni, and G Tossini, and G Visco
HIV, AIDS, and zidovudine.
March 1992, Lancet (London, England),
Copied contents to your clipboard!